KMID : 0368120100400100520
|
|
Korean Circulation Journal 2010 Volume.40 No. 10 p.520 ~ p.526
|
|
Alagebrium Chloride, a Novel Advanced Glycation End-Product Cross Linkage Breaker, Inhibits Neointimal Proliferation in a Diabetic Rat Carotid Balloon Injury Model
|
|
Kim Jin-Bae
Song Byeong-Wook Park Sung-Ha Hwang Ki-Chul Cha Bong-Soo Jang Yang-Soo Lee Hyun-Chul Lee Moon-Hyoung
|
|
Abstract
|
|
|
Background and Objectives: Vascular perturbation induced by advanced glycation end-products (AGEs) leads to progression of atherosclerosis, plaque instability, and vascular inflammation, which results in a higher risk of neointimal proliferation. Here we investigated the inhibitory effect of alagebrium chloride (ALT-711), a breaker of AGE-based cross links, on neointimal proliferation in a carotid artery balloon injury model in diabetic rats induced by streptozotocin (STZ).
Materials and Methods: Rat aortic vascular smooth muscle cells (RASMCs) were treated with 1-100 ¥ìM of alagebrium added 24 hours before the addition of AGEs. This in vivo study was done using 8-week-old male rats that were injected intraperitoneally with 80 mg/kg STZ. Sixteen weeks later, the diabetic rats were treated with 10 mg/kg alagebrium for 4 weeks, after which carotid artery balloon injury was induced. After 4 weeks, the animals were sacrificed for histological analysis.
Results: Proliferation of RASMCs was significantly inhibited in alagebrium-treated cells. Alagebrium dose-dependently inhibited AGE-mediated formation of reactive oxygen species (ROS), extracellular signal-regulated kinase phosphorylation, and cyclooxygenase-2 expression. The cellular mechanisms of AGE-induced connective tissue and extracellular matrix expression were decreased in the alagebrium-treated group. This in vivo study shows that expression of AGE receptors and neointima hyperplasia are significantly suppressed in balloon-injured rats treated with alagebrium.
Conclusion: Alagebrium treatment in diabetic rats significantly inhibits neointimal hyperplasia after carotid balloon injury due to its inhibition of intracellular ROS synthesis, which results in inhibition of RASMCs proliferation.
|
|
KEYWORD
|
|
Alagebrium, Advanced glycation end-products, Neointimal hyperplasia
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|